• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

SCO­TUS of­fers an­oth­er short-term ex­ten­sion for abor­tion pil­l's ap­proval

3 years ago
Law

FDA's pain ad­comm de­bates clin­i­cal tri­al de­signs for opi­oid post-mar­ket­ing tri­als

3 years ago
R&D
Pharma

Leg­end rais­es $200M from pri­vate in­vestor af­ter con­fer­ence leaks PhI­II Carvyk­ti da­ta

3 years ago
Financing
Cell/Gene Tx

Ire­land added to EMA/FDA joint gener­ic in­spec­tion ini­tia­tive

3 years ago
FDA+
Manufacturing

As Eli Lil­ly's Moun­jaro pre­scrip­tions sky­rock­et, an­a­lyst pre­dicts $50B in year­ly tirzepatide sales

3 years ago
Pharma
Marketing

Trade union calls for walk­outs at GSK man­u­fac­tur­ing sites in the UK

3 years ago
People
Manufacturing

Four se­nior FDA lead­ers forged close ties with Bio­gen well ahead of Aduhelm's ap­proval. Now they've left FDA

3 years ago
People
FDA+

Karyopharm stock drops af­ter in­hibitor's PhI da­ta show low­er dose not as ef­fec­tive: #AACR23

3 years ago
R&D

Gami­da Cell looks to get $22M+ on its pub­lic of­fer­ing launch; Es­pe­ri­on signs co-pro­mo­tion pact with Cur­rax

3 years ago
News Briefing

In a leaked ab­stract, J&J's cell ther­a­py ap­pears to have dra­mat­ic ben­e­fits for mul­ti­ple myelo­ma pa­tients

3 years ago
R&D
Pharma

Vax­cyte to raise $500M from stock of­fer­ing for PhI­II study of pneu­mo­coc­cal vac­cine

3 years ago
Financing

Roche's Foun­da­tion Med­i­cine lays off 135 work­ers

3 years ago
People

Gilde Health­care bags $657M to fu­el 'holis­tic' search for af­ford­able drugs, tech­nolo­gies

3 years ago
Financing

KRAS, one of can­cer’s tough­est tar­gets, sees a surge of new ther­a­pies try­ing to lim­it side ef­fects: #AACR23

3 years ago
R&D

Eu­ro­pean biotech VC For­bion clos­es two funds at $1.5B to­tal in its biggest rais­es to date

3 years ago
Financing

Ma­jor­i­ty of top-sell­ing Medicare drugs of­fer lit­tle added ben­e­fit to al­ter­na­tives, re­searchers find

3 years ago
Pharma
Law

Ab­b­Vie's Qulip­ta adds FDA ap­proval for chron­ic mi­graine

3 years ago
Pharma

FDA sim­pli­fies Covid-19 bi­va­lent vac­ci­na­tion process ahead of June ad­comm

3 years ago
Pharma
FDA+

J&J sales near $25B for Q1, with sol­id on­col­o­gy, im­munol­o­gy gains

3 years ago
Pharma

Palleon un­veils PhI look at 'lawn mow­er' ap­proach to gly­coim­munol­o­gy: #AACR23

3 years ago
People
R&D

Con­sumer trust in phar­ma in­dus­try holds steady amid eco­nom­ic, in­equal­i­ty un­easi­ness — Edel­man sur­vey

3 years ago
Pharma
Marketing

Mar­ket­ingRx roundup: Ei­sai part­ners on head and neck can­cer cam­paign; As­traZeneca, Dai­ichi ads pop up at AACR

3 years ago
Pharma
Marketing

Basilea push­es back FDA sub­mis­sion for an­tibi­ot­ic over CMO is­sues

3 years ago
R&D
Manufacturing

Ot­su­ka sub­sidiary gets date with FDA for Lon­surf com­bo; Vax­cyte sells stock to bankroll PhI­II vac­cine tri­al

3 years ago
News Briefing
First page Previous page 354355356357358359360 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times